re: Ann: Feasibility Study Data to Be Present... Woodsy,Interesting diversity of stock. I thought I was the only one into this med tech and gold combo ;)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%